These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 9692323)

  • 1. A study of cohesive patterns and dynamic choices utilized by two schizophrenic patients in dialog, pre- and post-medication.
    Abu-Akel A
    Lang Speech; 1997; 40 ( Pt 4)():331-51. PubMed ID: 9692323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
    Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
    Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quality of life of schizophrenic patients and clozapine].
    Raoul Y; Manesse P; Delage M
    Encephale; 1997 Sep; 23 Spec No 4():12-6. PubMed ID: 9417398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of antipsychotic medication on the linguistic ability of schizophrenics.
    Hymowitz P; Spohn H
    J Nerv Ment Dis; 1980 May; 168(5):287-96. PubMed ID: 6102593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gating of auditory P50 in schizophrenics: unique effects of clozapine.
    Nagamoto HT; Adler LE; Hea RA; Griffith JM; McRae KA; Freedman R
    Biol Psychiatry; 1996 Aug; 40(3):181-8. PubMed ID: 8830951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuroleptic modification of basic schizophrenic disorders].
    Heim M; Morgner J
    Psychiatr Neurol Med Psychol (Leipz); 1987 May; 39(5):274-80. PubMed ID: 2888144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of concurrent distraction on communication failures in schizophrenic patients. II. Medication status correlations.
    Moskowitz J; Davidson M; Harvey PD
    Schizophr Res; 1991 Sep; 5(2):153-9. PubMed ID: 1681891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychologic deficits in schizophrenia: relation to social function and effect of antipsychotic drug treatment.
    Meltzer HY; Thompson PA; Lee MA; Ranjan R
    Neuropsychopharmacology; 1996 Mar; 14(3 Suppl):27S-33S. PubMed ID: 8866741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine maintenance therapy in schizophrenia.
    Gaszner P; Makkos Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Practical aspects of drug resistance in schizophrenia].
    Jarema M; Kucińska M
    Psychiatr Pol; 2000; 34(5):721-40. PubMed ID: 11202015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive differences in schizophrenia on long-term treatments with clozapine, risperidone and typical antipsychotics.
    Han M; Zhang XY; Chen DC; Tan YL; Song CS; Yu YH; Huang XF
    Int Clin Psychopharmacol; 2015 Mar; 30(2):89-95. PubMed ID: 25568968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia.
    Lewis SW; Barnes TR; Davies L; Murray RM; Dunn G; Hayhurst KP; Markwick A; Lloyd H; Jones PB
    Schizophr Bull; 2006 Oct; 32(4):715-23. PubMed ID: 16540702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heart rate variability in schizophrenic patients treated with antipsychotic agents].
    Cohen H; Loewenthal U; Matar M; Kotler M
    Harefuah; 2001 Dec; 140(12):1142-7, 1231. PubMed ID: 11789296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance abuse in clozapine-treated schizophrenic patients.
    Sand PG; Soyka M
    J Neuropsychiatry Clin Neurosci; 1997; 9(4):626-7. PubMed ID: 9447510
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of clozapine and risperidone on spatial working memory in schizophrenia.
    McGurk SR; Carter C; Goldman R; Green MF; Marder SR; Xie H; Schooler NR; Kane JM
    Am J Psychiatry; 2005 May; 162(5):1013-6. PubMed ID: 15863811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Greater clinical and cognitive improvement with clozapine and risperidone associated with a thinner cortex at baseline in first-episode schizophrenia.
    Molina V; Taboada D; Aragüés M; Hernández JA; Sanz-Fuentenebro J
    Schizophr Res; 2014 Sep; 158(1-3):223-9. PubMed ID: 25088730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between cortical inhibition, antipsychotic treatment, and the symptoms of schizophrenia.
    Liu SK; Fitzgerald PB; Daigle M; Chen R; Daskalakis ZJ
    Biol Psychiatry; 2009 Mar; 65(6):503-9. PubMed ID: 18950746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal dynamics of language in schizophrenia.
    Stephane M; Kuskowski M; Gundel J
    Psychiatry Res; 2014 May; 216(3):320-4. PubMed ID: 24629711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic-resistant schizophrenia treated with clozapine and ECT.
    Benatov R; Sirota P; Megged S
    Convuls Ther; 1996 Jun; 12(2):117-21. PubMed ID: 8744173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum S100B levels in chronic schizophrenic patients on long-term clozapine or typical antipsychotics.
    Qi LY; Xiu MH; Chen DC; Wang F; Kosten TA; Kosten TR; Zhang XY
    Neurosci Lett; 2009 Sep; 462(2):113-7. PubMed ID: 19539717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.